Compared to control group, patients of the CAD group have an increased percentage of obesity, MetS, hypertension, insulin and BMI, TG, and LDL-C levels (all p < 0.05). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.